Stockscreener 앱 받기
5.49
1.48%
0.08
Chromadex Corp 주식(CDXC)의 최신 뉴스
The Manufacturers Life Insurance Company Has $72,000 Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to Buy Rating by StockNews.com - Defense World
ChromaDex (NASDAQ:CDXC) Lowered to "Buy" Rating by StockNews.com - MarketBeat
ChromaDex appoints Crowe as new auditor - Investing.com
BNP Paribas Financial Markets Increases Position in ChromaDex Co. (NASDAQ:CDXC) - Defense World
Frank L. Jaksch, Jr. Sells 37,161 Shares of ChromaDex Co. (NASDAQ:CDXC) Stock - MarketBeat
Chromadex director Frank Jaksch sells $229,955 in stock - Investing.com
Even though ChromaDex (NASDAQ:CDXC) has lost US$73m market cap in last 7 days, shareholders are still up 389% over 1 year - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Upgraded by StockNews.com to Strong-Buy Rating - Defense World
ChromaDex (CDXC) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Shares Gap UpTime to Buy? - MarketBeat
ChromaDex maintains Buy rating on recent agreement By Investing.com - Investing.com Canada
ChromaDex maintains Buy rating on recent agreement - Investing.com
ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category - The Bakersfield Californian
ChromaDex stock soars to 52-week high, hits $7.87 By Investing.com - Investing.com Nigeria
ChromaDex stock soars to 52-week high, hits $7.87 - Investing.com
Tru Niagen’s Canadian retail footprint now includes Whole Foods in Ontario - NutraIngredients-usa.com
ChromaDex Co. (NASDAQ:CDXC) CFO Ozan Pamir Buys 2,907 Shares - MarketBeat
Chromadex CFO Pamir Ozan acquires $21,396 in company stock By Investing.com - Investing.com Australia
Chromadex CFO Pamir Ozan acquires $21,396 in company stock - Investing.com India
Insider Buying: Ozan Pamir Acquires Shares of ChromaDex Corp (CD - GuruFocus.com
ChromaDex (NASDAQ:CDXC) Shares Down 5.5%What's Next? - MarketBeat
ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
ChromaDex updates equity offering program, adds Roth Capital Partners - Investing.com
ChromaDex updates equity offering program, adds Roth Capital Partners By Investing.com - Investing.com Nigeria
Recent Price Trend in ChromaDex (CDXC) is Your Friend, Here's Why - Yahoo Finance
ChromaDex Gears Up to Report Q3 Earnings: Here's What to Expect - MSN
ChromaDex stock soars to 52-week high, hits $7.58 By Investing.com - Investing.com Australia
ChromaDex stock soars to 52-week high, hits $7.58 - Investing.com
ChromaDex Co. (NASDAQ:CDXC) Short Interest Update - MarketBeat
ChromaDex Expands Niagen IV Access to 200+ Restore Hyper Wellness Clinics - Athletech News
, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement - Business Wire
ChromaDex (NASDAQ:CDXC) Sets New 12-Month HighHere's Why - MarketBeat
ChromaDex stock soars to 52-week high, hits $7.08 - Investing.com
ChromaDex (NASDAQ:CDXC) Cut to "Buy" at StockNews.com - MarketBeat
What Makes ChromaDex (CDXC) a Strong Momentum Stock: Buy Now? - Yahoo Finance
ChromaDex rolls out Niagen IV at wellness centers By Investing.com - Investing.com Australia
What is Roth Capital's Estimate for ChromaDex Q2 Earnings? - MarketBeat
ChromaDex rolls out Niagen IV at wellness centers - Investing.com India
ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide - Business Wire
Research Analysts Issue Forecasts for ChromaDex Q4 Earnings - MarketBeat
Shareholders Can Be Confident That ChromaDex's (NASDAQ:CDXC) Earnings Are High Quality - Yahoo Finance
ChromaDex (NASDAQ:CDXC) Hits New 12-Month High After Analyst Upgrade - Defense World
HC Wainwright Issues Positive Outlook for ChromaDex Earnings - MarketBeat
ChromaDex achieves financial stability with strong earnings report, soaring stock price - Natural Products Insider
2.20%
0.84%
자본화:
|
볼륨(24시간):